CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.

House, Imran G; Derrick, Emily B; Sek, Kevin; Chen, Amanda X Y; Li, Jasmine; Lai, Junyun; Todd, Kirsten L; Munoz, Isabelle; Michie, Jessica; Chan, Cheok Weng; Huang, Yu-Kuan; Chan, Jack D; Petley, Emma V; Tong, Junming; Nguyen, DatMinh; Engel, Sven; Savas, Peter; Hogg, Simon J; Vervoort, Stephin J; Kearney, Conor J; Burr, Marian L; Lam, Enid Y N; Gilan, Omer; Bedoui, Sammy; Johnstone, Ricky W; Dawson, Mark A; Loi, Sherene; Darcy, Phillip K; Beavis, Paul A

House, Imran G; Derrick, Emily B; Sek, Kevin; Chen, Amanda X Y; Li, Jasmine; Lai, Junyun; Todd, Kirsten L; Munoz, Isabelle; Michie, Jessica; Chan, Cheok Weng; Huang, Yu-Kuan; Chan, Jack D; Petley, Emma V; Tong, Junming; Nguyen, DatMinh; Engel, Sven; Savas, Peter; Hogg, Simon J; Vervoort, Stephin J; Kearney, Conor J; Burr, Marian L; Lam, Enid Y N; Gilan, Omer; Bedoui, Sammy; Johnstone, Ricky W; Dawson, Mark A; Loi, Sherene; Darcy, Phillip K; Beavis, Paul A.

Cell Rep ; 43(2): 113793, 2024 Feb 27.

Article in En | MEDLINE | ID: mdl-38324452

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Cell Rep Year: 2024 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Cell Rep Year: 2024 Type: Article